{"id":"tp-58393","type":"article-newspaper","title":"Instil Bio Posts $0.62 GAAP Loss Per Share, $0.48 Non-GAAP Loss Per Share","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/58393","datePublished":"2026-11-16T13:38:24.000Z","dateModified":"2026-11-16T13:38:24.000Z","language":"en","abstract":"Instil Bio expects its $67.1 million in cash, cash equivalents, restricted cash, marketable securities and long-term investments to fund its operating plan through 2027.","section":"Business","references":[]}